Hernández-Muñoz R, Díaz-Muñoz M, Suárez J, Chagoya de Sánchez V
Departamento de Bioenergética, Universidad Nacional Autónoma de México, D.F.
Hepatology. 1990 Aug;12(2):242-8. doi: 10.1002/hep.1840120210.
Adenosine administration was tested in rats with carbon tetrachloride-induced hepatic fibrosis and was able to partially prevent the enlargement of liver and spleen induced by the toxin. This amelioration of the hepatomegaly was accompanied by a 50% reduction of the liver collagen deposition and preservation of content of glycosaminoglycans. A stimulated hepatic collagenase activity is apparently the mechanism for reduction of collagen accumulation. These effects were associated with a striking improvement in liver function. Adenosine treatment did not modify the late hepatotoxic effect of the carbon tetrachloride; however, the stimulatory effect of the nucleoside on energy state appeared to counteract the drastic decreases in adenine nucleotides, ATP, ATP/ADP ratio and energy charge elicited by the hepatotoxin. Moreover, a possible beneficial action of enhanced hepatic oxygenation caused by the vasodilator properties of adenosine cannot be ruled out. Regardless of the mechanism, adenosine seems to change the cellular response to the injury induced by the hepatotoxin.
在四氯化碳诱导的肝纤维化大鼠中测试了腺苷给药,其能够部分预防毒素诱导的肝脏和脾脏肿大。肝脏肿大的这种改善伴随着肝脏胶原蛋白沉积减少50%以及糖胺聚糖含量的保留。肝胶原酶活性的刺激显然是胶原蛋白积累减少的机制。这些作用与肝功能的显著改善相关。腺苷治疗并未改变四氯化碳的晚期肝毒性作用;然而,核苷对能量状态的刺激作用似乎抵消了肝毒素引起的腺嘌呤核苷酸、ATP、ATP/ADP比值和能量电荷的急剧下降。此外,不能排除腺苷的血管舒张特性引起的肝脏氧合增强的可能有益作用。无论机制如何,腺苷似乎改变了细胞对肝毒素诱导损伤的反应。